Back to Search Start Over

Risk factors for severe PCR-positive SARS-CoV-2 infection in hospitalized children: a multicenter cohort study

Authors :
Rosie Scuccimarri
Carmen Yea
Ali Manafi
Chelsea Caya
Karina A. Top
Kirk Leifso
Adriana Yock-Corrales
Tala El Tal
Alejandra Soriano-Fallas
Cheryl Foo
Ronald M. Laxer
Ann Bayliss
Behzad Haghighi Aski
Nicole Le Saux
Ashley Roberts
Dara Petel
Rachel Dwilow
Jared Bullard
Jesse Papenburg
Peter J Gill
Sarah Tehseen
Tammie Dewan
Manish Sadarangani
Ari Bitnun
Fatima Kakkar
Jennifer Bowes
Janell Lautermilch
Tilmann Schober
Dominique Piche
Rolando Ulloa-Gutierrez
Lea Restivo
Joan L. Robinson
Rupeena Purewal
Michelle Barton
Suzette Cooke
Isabelle Viel-Theriaul
Helena Brenes-Chacon
Ann Yeh
Jacqueline Wong
Shaun K. Morris
Alireza Nateghian
Marie-Astrid Lefebvre
Alison Lopez
Luc Panetta
Publication Year :
2021
Publisher :
Cold Spring Harbor Laboratory, 2021.

Abstract

ImportanceChildren are less likely than adults to have severe outcomes from SARS-CoV-2 infection and the corresponding risk factors are not well established.ObjectiveTo identify risk factors for severe disease in symptomatic children hospitalized for PCR-positive SARS-CoV-2 infection.DesignCohort study, enrollment from February 1, 2020 until May 31, 2021Setting15 children’s hospitals in Canada, Iran, and Costa RicaParticipantsPatients ExposuresVariables assessed for their association with disease severity included patient demographics, presence of comorbidities, clinical manifestations, laboratory parameters and chest imaging findings.Main Outcomes and MeasuresThe primary outcome was severe disease defined as a WHO COVID-19 clinical progression scale of ≥6, i.e., requirement of non-invasive ventilation, high flow nasal cannula, mechanical ventilation, vasopressors, or death. Multivariable logistic regression was used to evaluate factors associated with severe disease.ResultsWe identified 403 hospitalizations. Median age was 3.78 years (IQR 0.53-10.77). At least one comorbidity was present in 46.4% (187/403) and multiple comorbidities in 18.6% (75/403). Severe disease occurred in 33.8% (102/403). In multivariable analyses, presence of multiple comorbidities (adjusted odds ratio 2.24, 95% confidence interval 1.04-4.81), obesity (2.87, 1.19-6.93), neurological disorder (3.22, 1.37-7.56), anemia, and/or hemoglobinopathy (5.88, 1.30-26.46), shortness of breath (4.37, 2.08-9.16), bacterial and/or viral coinfections (2.26, 1.08-4.73), chest imaging compatible with COVID-19 (2.99, 1.51-5.92), neutrophilia (2.60, 1.35-5.02), and MIS-C diagnosis (3.86, 1.56-9.51) were independent risk factors for severity. Comorbidities, especially obesity (40.9% vs 3.9%, pConclusions and RelevancePediatric risk factors for severe SARS-CoV-2 infection vary according to age and can potentially guide vaccination programs and treatment approaches in children.Key pointsQuestionWhat are the risk factors for severe disease in children hospitalized for PCR-positive SARS-CoV-2 infection?FindingsIn this multinational cohort study of 403 children, multiple comorbidities, obesity, neurological disorder, anemia, and/or hemoglobinopathy, shortness of breath, bacterial and/or viral coinfections, chest imaging compatible with COVID-19, neutrophilia, and MIS-C diagnosis were independent risk factors for severity. The risk profile and presence of comorbidities differed between pediatric age groups, but age itself was not associated with severe outcomes.MeaningThese results can inform targeted treatment approaches and vaccine programs that focus on patient groups with the highest risk of severe outcomes.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........6597f522f5c64b8255e09cc9af9f4f1a
Full Text :
https://doi.org/10.1101/2021.10.28.21265616